Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

High-Temperature Selective Emitter Design and Materials: Titanium Aluminum Nitride Alloys for Thermophotovoltaics.

Jeon N, Mandia DJ, Gray SK, Foley JJ 4th, Martinson ABF.

ACS Appl Mater Interfaces. 2019 Nov 6;11(44):41347-41355. doi: 10.1021/acsami.9b13944. Epub 2019 Oct 25.

PMID:
31652047
2.

Functionally Related Genes Cluster into Genomic Regions That Coordinate Transcription at a Distance in Saccharomyces cerevisiae.

Cera A, Holganza MK, Hardan AA, Gamarra I, Eldabagh RS, Deschaine M, Elkamhawy S, Sisso EM, Foley JJ 4th, Arnone JT.

mSphere. 2019 Mar 13;4(2). pii: e00063-19. doi: 10.1128/mSphere.00063-19.

3.

Systematic Identification, Characterization, and Conservation of Adjacent-Gene Coregulation in the Budding Yeast Saccharomyces cerevisiae.

Eldabagh RS, Mejia NG, Barrett RL, Monzo CR, So MK, Foley JJ 4th, Arnone JT.

mSphere. 2018 Jun 13;3(3). pii: e00220-18. doi: 10.1128/mSphere.00220-18. Print 2018 Jun 27.

4.

Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues.

Hegde SS, Pulido-Rios MT, Luttmann MA, Foley JJ, Hunsberger GE, Steinfeld T, Lee T, Ji Y, Mammen MM, Jasper JR.

Pharmacol Res Perspect. 2018 Apr 30;6(3):e00400. doi: 10.1002/prp2.400. eCollection 2018 Jun.

5.

TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis.

Laping NJ, DeMartino MP, Cottom JE, Axten JM, Emery JG, Guss JH, Burman M, Foley JJ, Cheung M, Oliff A, Kumar S.

Blood Adv. 2017 Dec 8;1(26):2553-2562. doi: 10.1182/bloodadvances.2017010611. eCollection 2017 Dec 12.

6.

Ultraconfined Plasmonic Hotspots Inside Graphene Nanobubbles.

Fei Z, Foley JJ 4th, Gannett W, Liu MK, Dai S, Ni GX, Zettl A, Fogler MM, Wiederrecht GP, Gray SK, Basov DN.

Nano Lett. 2016 Dec 14;16(12):7842-7848. Epub 2016 Nov 14.

PMID:
27960518
7.

Design of emitter structures based on resonant perfect absorption for thermophotovoltaic applications.

Foley JJ, Ungaro C, Sun K, Gupta MC, Gray SK.

Opt Express. 2015 Nov 30;23(24):A1373-87. doi: 10.1364/OE.23.0A1373.

PMID:
26698788
8.

Reversible Modulation of Surface Plasmons in Gold Nanoparticles Enabled by Surface Redox Chemistry.

Li Z, Foley JJ 4th, Peng S, Sun CJ, Ren Y, Wiederrecht GP, Gray SK, Sun Y.

Angew Chem Int Ed Engl. 2015 Jul 27;54(31):8948-51. doi: 10.1002/anie.201502012. Epub 2015 Jun 11.

PMID:
26094976
9.

Interfaced metal heterodimers in the quantum size regime.

Sun Y, Foley JJ 4th, Peng S, Li Z, Gray SK.

Nano Lett. 2013 Aug 14;13(8):3958-64. doi: 10.1021/nl402361b. Epub 2013 Jul 26.

PMID:
23879377
10.

Cage versus prism: electronic energies of the water hexamer.

Foley JJ 4th, Mazziotti DA.

J Phys Chem A. 2013 Aug 1;117(30):6712-6. doi: 10.1021/jp405739d. Epub 2013 Jul 10.

PMID:
23841757
11.

Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.

Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Lainé DI, Hay DW, Rumsey WL.

J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22.

PMID:
23435542
12.

Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups.

Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J.

Bioorg Med Chem Lett. 2012 Dec 1;22(23):7087-91. doi: 10.1016/j.bmcl.2012.09.085. Epub 2012 Oct 2.

PMID:
23099092
13.

Evaluation of pharmacist utilization of a poison center as a resource for patient care.

Armahizer MJ, Johnson D, Deusenberry CM, Foley JJ, Krenzelok EP, Pummer TL.

J Pharm Pract. 2013 Jun;26(3):220-7. doi: 10.1177/0897190012451911. Epub 2012 Jul 25.

PMID:
22842499
14.

Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.

Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J.

Bioorg Med Chem Lett. 2012 May 1;22(9):3366-9. doi: 10.1016/j.bmcl.2012.02.015. Epub 2012 Feb 15.

PMID:
22460029
15.

Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice.

Walker EA, Foley JJ, Clark-Vetri R, Raffa RB.

Psychopharmacology (Berl). 2011 Oct;217(4):539-48. doi: 10.1007/s00213-011-2310-8. Epub 2011 May 3.

16.

Strongly correlated mechanisms of a photoexcited radical reaction from the anti-Hermitian contracted Schrödinger equation.

Foley JJ 4th, Rothman AE, Mazziotti DA.

J Chem Phys. 2011 Jan 21;134(3):034111. doi: 10.1063/1.3526298.

PMID:
21261334
17.

2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.

Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J.

Bioorg Med Chem Lett. 2010 Jun 15;20(12):3540-4. doi: 10.1016/j.bmcl.2010.04.128. Epub 2010 May 17.

PMID:
20483611
18.

Conical intersections in triplet excited states of methylene from the anti-Hermitian contracted Schrödinger equation.

Snyder JW Jr, Rothman AE, Foley JJ 4th, Mazziotti DA.

J Chem Phys. 2010 Apr 21;132(15):154109. doi: 10.1063/1.3394020.

PMID:
20423170
19.

Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure.

Walker EA, Foley JJ.

Behav Pharmacol. 2010 Mar;21(2):83-9. doi: 10.1097/FBP.0b013e328337bde7.

20.

Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.

Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M.

Bioorg Med Chem Lett. 2009 Aug 15;19(16):4560-2. doi: 10.1016/j.bmcl.2009.07.006. Epub 2009 Jul 8.

PMID:
19616944
21.

Activation energies of sigmatropic shifts in propene and acetone enolate from the anti-Hermitian contracted Schrödinger equation.

Foley JJ 4th, Rothman AE, Mazziotti DA.

J Chem Phys. 2009 May 14;130(18):184112. doi: 10.1063/1.3129922.

PMID:
19449913
22.

Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.

Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M.

J Med Chem. 2009 Apr 23;52(8):2493-505. doi: 10.1021/jm801601v.

PMID:
19317446
23.

Optimized procedures for producing biologically active chemokines.

Lu Q, Burns MC, McDevitt PJ, Graham TL, Sukman AJ, Fornwald JA, Tang X, Gallagher KT, Hunsberger GE, Foley JJ, Schmidt DB, Kerrigan JJ, Lewis TS, Ames RS, Johanson KO.

Protein Expr Purif. 2009 Jun;65(2):251-60.

PMID:
19297698
24.

M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.

Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J.

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1686-90. doi: 10.1016/j.bmcl.2009.01.098. Epub 2009 Feb 4.

PMID:
19243945
25.

Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.

Wang Y, Busch-Petersen J, Wang F, Kiesow TJ, Graybill TL, Jin J, Yang Z, Foley JJ, Hunsberger GE, Schmidt DB, Sarau HM, Capper-Spudich EA, Wu Z, Fisher LS, McQueney MS, Rivero RA, Widdowson KL.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):114-8. doi: 10.1016/j.bmcl.2008.11.008. Epub 2008 Nov 6.

PMID:
19014886
26.

Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.

Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5481-6. doi: 10.1016/j.bmcl.2008.09.020. Epub 2008 Sep 10.

PMID:
18818072
27.

Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.

Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI.

J Med Chem. 2008 Oct 9;51(19):5915-8. doi: 10.1021/jm800935u. Epub 2008 Sep 18.

PMID:
18798607
28.

Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.

Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J.

J Med Chem. 2008 Aug 28;51(16):4866-9. doi: 10.1021/jm800634k. Epub 2008 Aug 5.

PMID:
18680280
29.

Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.

Jin J, An M, Sapienza A, Aiyar N, Naselsky D, Sarau HM, Foley JJ, Salyers KL, Knight SD, Keenan RM, Rivero RA, Dhanak D, Douglas SA.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3950-4. doi: 10.1016/j.bmcl.2008.06.019. Epub 2008 Jun 10.

PMID:
18573659
30.

Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.

Foley JJ, Raffa RB, Walker EA.

Psychopharmacology (Berl). 2008 Sep;199(4):527-38. doi: 10.1007/s00213-008-1175-y. Epub 2008 May 8.

31.

Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.

Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE.

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6066-9. Epub 2007 Sep 25.

PMID:
17911022
32.

3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists.

Wang Y, Busch-Petersen J, Wang F, Ma L, Fu W, Kerns JK, Jin J, Palovich MR, Shen JK, Burman M, Foley JJ, Schmidt DB, Hunsberger GE, Sarau HM, Widdowson KL.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3864-7. Epub 2007 May 10.

PMID:
17524641
33.

Oxazolidinones as novel human CCR8 antagonists.

Jin J, Wang Y, Wang F, Kerns JK, Vinader VM, Hancock AP, Lindon MJ, Stevenson GI, Morrow DM, Rao P, Nguyen C, Barrett VJ, Browning C, Hartmann G, Andrew DP, Sarau HM, Foley JJ, Jurewicz AJ, Fornwald JA, Harker AJ, Moore ML, Rivero RA, Belmonte KE, Connor HE.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1722-5. Epub 2006 Dec 24.

PMID:
17267215
34.

Comparison of N,N'-diarylsquaramides and N,N'-diarylureas as antagonists of the CXCR2 chemokine receptor.

McCleland BW, Davis RS, Palovich MR, Widdowson KL, Werner ML, Burman M, Foley JJ, Schmidt DB, Sarau HM, Rogers M, Salyers KL, Gorycki PD, Roethke TJ, Stelman GJ, Azzarano LM, Ward KW, Busch-Petersen J.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1713-7. Epub 2006 Dec 23.

PMID:
17236763
35.

N,N'-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors.

Nie H, Widdowson KL, Palovich MR, Fu W, Elliott JD, Bryan DL, Burman M, Schmidt DB, Foley JJ, Sarau HM, Busch-Petersen J.

Bioorg Med Chem Lett. 2006 Nov 1;16(21):5513-6. Epub 2006 Aug 24.

PMID:
16934456
36.

The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.

Behm DJ, Stankus G, Doe CP, Willette RN, Sarau HM, Foley JJ, Schmidt DB, Nuthulaganti P, Fornwald JA, Ames RS, Lambert DG, Calo' G, Camarda V, Aiyar NV, Douglas SA.

Br J Pharmacol. 2006 May;148(2):173-90.

37.

Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.

Jin J, Dhanak D, Knight SD, Widdowson K, Aiyar N, Naselsky D, Sarau HM, Foley JJ, Schmidt DB, Bennett CD, Wang B, Warren GL, Moore ML, Keenan RM, Rivero RA, Douglas SA.

Bioorg Med Chem Lett. 2005 Jul 1;15(13):3229-32.

PMID:
15936190
38.

Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.

Douglas SA, Behm DJ, Aiyar NV, Naselsky D, Disa J, Brooks DP, Ohlstein EH, Gleason JG, Sarau HM, Foley JJ, Buckley PT, Schmidt DB, Wixted WE, Widdowson K, Riley G, Jin J, Gallagher TF, Schmidt SJ, Ridgers L, Christmann LT, Keenan RM, Knight SD, Dhanak D.

Br J Pharmacol. 2005 Jul;145(5):620-35.

39.

Cloning and pharmacological characterization of the cat urotensin-II receptor (UT).

Aiyar N, Johns DG, Ao Z, Disa J, Behm DJ, Foley JJ, Buckley PT, Sarau HM, van-der-Keyl HK, Elshourbagy NA, Douglas SA.

Biochem Pharmacol. 2005 Apr 1;69(7):1069-79.

PMID:
15763543
40.

Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1.

Johnson EN, Appelbaum ER, Carpenter DC, Cox RF, Disa J, Foley JJ, Ghosh SK, Naselsky DP, Pullen MA, Sarau HM, Scheff SR, Steplewski KM, Zaks-Zilberman M, Aiyar N.

J Immunol. 2004 Dec 15;173(12):7230-8.

41.

A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma.

Pillai SG, Cousens DJ, Barnes AA, Buckley PT, Chiano MN, Hosking LK, Cameron LA, Fling ME, Foley JJ, Green A, Sarau HM, Schmidt DB, Sprankle CS, Blumenthal MN, Vestbo J, Kennedy-Wilson K, Wixted WE, Wagner MJ, Anderson WH, Ignar DM; Investigators of the GAIN Network.

Pharmacogenetics. 2004 Sep;14(9):627-33.

PMID:
15475736
42.

Radioligand binding and functional characterization of recombinant human NmU1 and NmU2 receptors stably expressed in clonal human embryonic kidney-293 cells.

Aiyar N, Disa J, Foley JJ, Buckley PT, Wixted WE, Pullen M, Shabon U, Dul E, Szekeres PG, Elshourbagy NA, Sarau HM, Appelbaum E, Bolaky J.

Pharmacology. 2004 Sep;72(1):33-41.

PMID:
15292653
43.

Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.

Widdowson KL, Elliott JD, Veber DF, Nie H, Rutledge MC, McCleland BW, Xiang JN, Jurewicz AJ, Hertzberg RP, Foley JJ, Griswold DE, Martin L, Lee JM, White JR, Sarau HM.

J Med Chem. 2004 Mar 11;47(6):1319-21.

PMID:
14998320
44.

Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease.

Hardaker EL, Bacon AM, Carlson K, Roshak AK, Foley JJ, Schmidt DB, Buckley PT, Comegys M, Panettieri RA Jr, Sarau HM, Belmonte KE.

FASEB J. 2004 Jan;18(1):191-3. Epub 2003 Nov 3.

PMID:
14597565
45.

The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors.

Herold CL, Behm DJ, Buckley PT, Foley JJ, Wixted WE, Sarau HM, Douglas SA.

Br J Pharmacol. 2003 May;139(2):203-7.

46.

A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit.

Podolin PL, Bolognese BJ, Foley JJ, Schmidt DB, Buckley PT, Widdowson KL, Jin Q, White JR, Lee JM, Goodman RB, Hagen TR, Kajikawa O, Marshall LA, Hay DW, Sarau HM.

J Immunol. 2002 Dec 1;169(11):6435-44.

47.

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM.

J Pharmacol Exp Ther. 2002 Jan;300(1):314-23.

PMID:
11752131
48.

Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.

Ames RS, Lee D, Foley JJ, Jurewicz AJ, Tornetta MA, Bautsch W, Settmacher B, Klos A, Erhard KF, Cousins RD, Sulpizio AC, Hieble JP, McCafferty G, Ward KW, Adams JL, Bondinell WE, Underwood DC, Osborn RR, Badger AM, Sarau HM.

J Immunol. 2001 May 15;166(10):6341-8.

49.

Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.

Sarau HM, Feild JA, Ames RS, Foley JJ, Nuthulaganti P, Schmidt DB, Buckley PT, Elshourbagy NA, Brawner ME, Luttmann MA, Giardina GA, Hay DW.

Eur J Pharmacol. 2001 Feb 16;413(2-3):143-50.

PMID:
11226387
50.

A G protein-coupled receptor for UDP-glucose.

Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, Trill J, Swift A, Aiyar N, Taylor P, Vawter L, Naheed S, Szekeres P, Hervieu G, Scott C, Watson JM, Murphy AJ, Duzic E, Klein C, Bergsma DJ, Wilson S, Livi GP.

J Biol Chem. 2000 Apr 14;275(15):10767-71.

Supplemental Content

Loading ...
Support Center